|
RAB11FIP5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
3.17159964957625E-10 |
| Normal-vs-Stage3 |
2.30830021763495E-10 |
| Normal-vs-Stage4 |
4.34989999575919E-08 |
| Stage1-vs-Stage2 |
7.032000E-01 |
| Stage1-vs-Stage3 |
7.526000E-01 |
| Stage1-vs-Stage4 |
5.583000E-01 |
| Stage2-vs-Stage3 |
5.845800E-01 |
| Stage2-vs-Stage4 |
7.864600E-01 |
| Stage3-vs-Stage4 |
4.754000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.31630262245608E-11 |
| Normal-vs-Asian |
2.29689999999838E-05 |
| Caucasian-vs-AfricanAmerican |
2.056800E-01 |
| Caucasian-vs-Asian |
6.775400E-01 |
| AfricanAmerican-vs-Asian |
4.328200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.04249950286339E-10 |
| Male-vs-Female |
2.509800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.74644759659759E-12 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
2.86126677906395E-12 |
| Normal-vs-Extreme_Obese |
1.179140E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.123200E-01 |
| Normal_Weight-vs-Obese |
3.286400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.776400E-02 |
| Extreme_Weight-vs-Obese |
7.096600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.019600E-02 |
| Obese-vs-Extreme_Obese |
1.854190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.70159999996122E-06 |
| Normal-vs-Age(41-60Yrs) |
3.77475828372553E-14 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.02009999838992E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.059000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.223840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.042800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.940400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.735800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.148800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.8421709430404E-14 |
| Normal-VS-KIRP CIMP |
2.19729999999529E-05 |
| Normal-VS-Unclassified PRCC |
4.60249949263414E-10 |
| Type1 PRCC-VS-Type2 PRCC |
8.205600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.147400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.603400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.716000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.477000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.998600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.61852778244065E-14 |
| Normal-vs-N1 |
3.61070062737667E-11 |
| Normal-vs-N2 |
2.379100E-03 |
| N0-vs-N1 |
8.206600E-01 |
| N0-vs-N2 |
3.902800E-01 |
| N1-vs-N2 |
4.041200E-01 |
|
|
